Hi, I posted on 20/4 an article regarding when to buy recovery stories (from Maven funds). We had a perfect example yesterday with Integrated Research (IRI).
I was keen to buy this stock, but was still hesitating as I wanted a confirmation of their recovery. We had this confirmation yesterday with their update. So, I bought the stock and missed the first 30 % increase. But I continue to think that's the best strategy with this kind of stock, as they are so undervalued before the news that it is not a problem to miss the first part of the rebound. Quite surprising that even after yesterday's rebound (+ 54 %), the stock remains really cheap for a software company : EV/EBITDA 24 of less than 4 x and free cash flow yield of 9.2 %.
